Bildkälla: Stockfoto

Active Biotech: New Results from Naptumomab - Redeye

Redeye comments on the readout from the phase IIa study of naptumomab in combination with docetaxel in lung cancer conducted by NeoTX.

Redeye comments on the readout from the phase IIa study of naptumomab in combination with docetaxel in lung cancer conducted by NeoTX.
Börsvärldens nyhetsbrev
ANNONSER